A detailed history of Ashton Thomas Private Wealth, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 2,291 shares of VRTX stock, worth $1.15 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,291
Previous 2,339 2.05%
Holding current value
$1.15 Million
Previous $1.1 Billion 2.81%
% of portfolio
0.06%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$460.0 - $505.78 $22,080 - $24,277
-48 Reduced 2.05%
2,291 $1.07 Billion
Q2 2024

Aug 06, 2024

BUY
$392.81 - $485.53 $36,531 - $45,154
93 Added 4.14%
2,339 $1.1 Billion
Q1 2024

Apr 19, 2024

BUY
$407.69 - $446.08 $122,307 - $133,824
300 Added 15.42%
2,246 $939 Million
Q4 2023

Apr 19, 2024

BUY
$343.0 - $410.68 $357,749 - $428,339
1,043 Added 115.5%
1,946 $792 Million
Q3 2023

Apr 19, 2024

SELL
$338.18 - $362.46 $8,792 - $9,423
-26 Reduced 2.8%
903 $314 Million
Q2 2023

Apr 22, 2024

BUY
$314.42 - $351.91 $7,546 - $8,445
24 Added 2.76%
892 $314 Million
Q1 2023

Apr 22, 2024

SELL
$283.23 - $323.1 $390,290 - $445,231
-1,378 Reduced 61.35%
868 $273 Million
Q4 2022

Apr 19, 2024

BUY
$285.76 - $321.48 $16,002 - $18,002
56 Added 6.41%
929 $268 Million
Q3 2022

Apr 19, 2024

SELL
$273.83 - $305.53 $19,441 - $21,692
-71 Reduced 7.52%
873 $253 Million
Q2 2022

Apr 19, 2024

BUY
$234.96 - $292.55 $12,922 - $16,090
55 Added 6.19%
944 $266 Million
Q1 2022

Apr 19, 2024

BUY
$221.42 - $260.97 $196,842 - $232,002
889 New
889 $232 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Ashton Thomas Private Wealth, LLC Portfolio

Follow Ashton Thomas Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.